Phase 1/2a Study of SQ3370 in Patients With Advanced Solid Tumors
Shasqi, Inc.
Shasqi, Inc.
Institut Bergonié
Leap Therapeutics, Inc.
Institut Bergonié
Roswell Park Cancer Institute
Elevation Oncology
Stanford University
Deciphera Pharmaceuticals, LLC
BeiGene
Mundipharma Research Limited
Rain Oncology Inc
NantCell, Inc.
Pfizer
Memorial Sloan Kettering Cancer Center
Children's Oncology Group
pharmaand GmbH
Hoffmann-La Roche
Genmab
City of Hope Medical Center
Ludwig Institute for Cancer Research
GOG Foundation
Daiichi Sankyo
Masonic Cancer Center, University of Minnesota
Novartis
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.